BVMF/A1LG34 (BVMF/A1LG34)

Brazil Stock Exchange: BVMF/A1LG34 · BRL

R$207

+5.40 (+2.7%)· Recorded snapshot

Market cap	58.6B
Revenue (ttm)	21.5B
Net income (ttm)	2.5B
EPS (ttm)	R$9.18
P/E (trailing)	22.5x
P/E (forward)	13.4x
Volume	62
Beta	1.67

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.5B
Net income (ttm): 2.5B
EPS (ttm): R$9.18
P/E (trailing): 22.5x
P/E (forward): 13.4x
Market cap: 58.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E22.5

P25 n/aP50 n/aP75 n/a

ROE11.9

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All BVMF/A1LG34 indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-28
Employees	20,435
Employees change	-15
Employees growth	-0.07%
Enterprise value	BRL 53.1B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1997
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRA1LGBDR007
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Market cap	BRL 58.6B
Next earnings date	2027-02-03
Price	BRL 207.00
Price currency	BRL
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-28
Symbol	bvmf/A1LG34
Website	https://www.aligntech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	48.35x
Average P/E ratio (3Y)	34.24x
Average P/E ratio (5Y)	43.3x
Earnings yield	4.43%
EV/Earnings	20.84x
EV/EBIT	11.98x
EV/EBITDA	9.7x
EV/FCF	15.83x
EV/Sales	2.38x
FCF / EV yield	6.32%
FCF yield	5.72%
Forward P/E	13.39x
Graham number	126.2283
Graham upside	-39.02%
Lynch fair value	BRL 44.97
Lynch upside	-78.27%
P/(FCF - SBC) ratio	24.52x
P/(OCF - SBC) ratio	20.07x
P/B ratio	2.63x
P/E ratio	22.55x
P/FCF ratio	17.48x
P/OCF ratio	15.1x
P/S ratio	2.72x
Price / tangible book value	3.04x
Price/EBITDA ratio	11.67x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.84%
EBITDA margin	23.33%
Effective tax rate	23.65%
FCF margin	15.08%
Gross margin	71.72%
Operating margin	19.84%
Pretax margin	15.49%
Profit margin	11.83%
Profit per employee	BRL 124,680
Profitable quarters	24
Profitable years	16
Revenue per employee	BRL 1.1M
ROA	8.08%
ROA (5Y)	7.76%
ROCE	17.9%
ROE	11.91%
ROE (5Y)	13.3%
ROIC	19.31%
ROIC (5Y)	18.81%
SBC / revenue	4.47%
Tax / revenue	3.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	33.19%
EPS growth (Q)	143.59%
EPS growth (QoQ)	25.83%
EPS growth 10Y	11.37%
EPS growth 3Y	13.44%
EPS growth 5Y	-5.84%
EPS growth years	1
FCF growth	14.26%
FCF growth (Q)	47.59%
FCF growth (QoQ)	58.74%
FCF growth 3Y	-1.91%
FCF growth 5Y	-7.11%
Gross profit growth	8.37%
Gross profit growth (Q)	4.55%
Gross profit growth 3Y	3.96%
Gross profit growth 5Y	1.26%
Net income growth	29.99%
Net income growth (Q)	137.95%
Net income growth (QoQ)	24.7%
Net income growth 3Y	10.68%
Net income growth 5Y	-7.85%
Net income growth years	0
OCF growth	14.29%
OCF growth (Q)	-3.08%
OCF growth (QoQ)	-5.1%
OCF growth 10Y	11.79%
OCF growth 3Y	-5.32%
OCF growth 5Y	-10.16%
Operating income growth	30.63%
Operating income growth (Q)	23.7%
Operating income growth 3Y	11.45%
Operating income growth 5Y	-3.16%
Revenue growth	4.42%
Revenue growth (Q)	1.92%
Revenue growth (QoQ)	-3.92%
Revenue growth 10Y	15.12%
Revenue growth 3Y	2.99%
Revenue growth 5Y	2.06%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -530.7M
Depreciation and amortization	BRL 777.3M
EBIT	BRL 4.3B
EBITDA	BRL 5B
EPS	BRL 9.18
Financing cash flow	BRL -1.6B
Free cash flow	BRL 3.4B
Free cash flow minus SBC	BRL 2.4B
Gross profit	BRL 15.5B
Income taxes	BRL 789.3M
Investing cash flow	BRL -1.5B
Net cash flow	BRL 727.7M
Net income	BRL 2.5B
Operating cash flow minus SBC	BRL 2.9B
Operating income	BRL 4.3B
Revenue	BRL 21.5B
Stock-based compensation	BRL 962.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 314.15
Debt / EBITDA	0.11
Debt / equity	0.03
Debt / FCF	0.17
Goodwill	BRL 2.6B
Long-term assets	BRL 19.2B
Long-term liabilities	BRL 1.2B
Net cash (debt)	BRL 5.3B
Net cash / market cap	9.12%
Net cash growth	16.9%
Net debt / EBITDA	-1.06
Net debt / equity	-0.24
Net debt / FCF	-1.59
Piotroski F-Score	7
Property, plant and equipment	BRL 6.8B
Shareholders' equity	BRL 22.3B
Tangible book value	BRL 19.3B
Tangible book value per share	BRL 271.40
Total assets	BRL 33.8B
Total cash	BRL 5.9B
Total debt	BRL 581.7M
Total liabilities	BRL 11.5B
WACC	13.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	BRL 14.6B
Current liabilities	BRL 10.2B
Current ratio	1.42
Inventory turnover	5.19
Net working capital	BRL -1.7B
Quick ratio	1.21
Working capital	BRL 4.2B
Working capital turnover	31.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.39%
Shareholder yield	2.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 213.73
1D price change	2.68%
1M price change	8.19%
1M total return	8.19%
1W price change	9.72%
1W total return	9.72%
1Y price change	13.41%
1Y return CAGR	13.42%
1Y total return	13.41%
20-day SMA	BRL 202.25
200-day SMA	BRL 245.75
3M price change	-8.83%
3M total return	-8.83%
3Y price change	-13.52%
3Y return CAGR	-4.73%
3Y total return	-13.52%
50-day SMA	BRL 213.91
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 248.50
52-week high date	2026-02-10
52-week low	BRL 175.00
52-week low date	2026-10-05
5Y price change	-75.55%
5Y return CAGR	-24.55%
5Y total return	-75.55%
6M price change	-10.16%
6M total return	-10.16%
All-time high	BRL 987.05
All-time high date	2021-11-08
All-time low	BRL 164.56
All-time low date	2025-09-30
Average true range (ATR)	BRL 6.79
Average volume	22.5
Beta (5Y)	1.67
Change from 52-week high	-16.7%
Change from 52-week low	18.29%
Change from all-time high	-79.03%
Change from all-time low	25.79%
Change from open	0%
Day's gap	2.68%
Dollar volume	BRL 12,834
High price	BRL 207.00
Low price	BRL 207.00
Monthly RSI	42.49
Open price	BRL 207.00
Previous close	BRL 201.60
Price vs 150-day SMA	-3.15%
Price vs 20-day SMA	2.35%
Price vs 200-day SMA	-15.77%
Price vs 50-day SMA	-3.23%
Relative volume	2.76
RSI	52.04
Sharpe ratio	-0.63
Sharpe ratio (3Y)	0.17
Sortino ratio	-0.69
Sortino ratio (3Y)	0.34
Volume	62
Weekly RSI	45.44
YTD price change	-5.82%
YTD total return	-5.82%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66.8M
Shares change (QoQ)	-0.71%
Shares change (YoY)	-2.39%
Shares held by insiders	3.42%
Shares held by institutions	102.95%

Deeper analysis on BVMF/A1LG34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BVMF/A1LG34 report

Is a complete BVMF/A1LG34 research report available?

No complete published report is available for bvmf/A1LG34 (BVMF/A1LG34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

58.6B

Revenue (ttm)

21.5B

Net income (ttm)

2.5B

EPS (ttm)

R$9.18

P/E (trailing)

22.5x

P/E (forward)

13.4x

Volume

Beta

1.67

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-10-28

Employees

20,435

Employees change

-15

Employees growth

-0.07%

Enterprise value

BRL 53.1B

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1997

Industry

Medical Instruments & Supplies

Is primary listing

ISIN number

BRA1LGBDR007

Last earnings date

2026-10-28

Last refreshed

2026-10-29

Market cap

BRL 58.6B

Next earnings date

2027-02-03

Price

BRL 207.00

Price currency

BRL

Sector

Healthcare

SIC code

3843

Stock price date

2026-10-28

Symbol

bvmf/A1LG34

Website

https://www.aligntech.com

Metric

Value

Average P/E ratio (10Y)

48.35x

Average P/E ratio (3Y)

34.24x

Average P/E ratio (5Y)

43.3x

Earnings yield

4.43%

EV/Earnings

20.84x

EV/EBIT

11.98x

EV/EBITDA

9.7x

EV/FCF

15.83x

EV/Sales

2.38x

FCF / EV yield

6.32%

FCF yield

5.72%

Forward P/E

13.39x

Graham number

126.2283

Graham upside

-39.02%

Lynch fair value

BRL 44.97

Lynch upside

-78.27%

P/(FCF - SBC) ratio

24.52x

P/(OCF - SBC) ratio

20.07x

P/B ratio

2.63x

P/E ratio

22.55x

P/FCF ratio

17.48x

P/OCF ratio

15.1x

P/S ratio

2.72x

Price / tangible book value

3.04x

Price/EBITDA ratio

11.67x

Sector forward P/E

11.05x

Sector P/E

41.08x

Metric

Value

EBIT margin

19.84%

EBITDA margin

23.33%

Effective tax rate

23.65%

FCF margin

15.08%

Gross margin

71.72%

Operating margin

19.84%

Pretax margin

15.49%

Profit margin

11.83%

Profit per employee

BRL 124,680

Profitable quarters

Profitable years

Revenue per employee

BRL 1.1M

ROA

8.08%

ROA (5Y)

7.76%

ROCE

17.9%

ROE

11.91%

ROE (5Y)

13.3%

ROIC

19.31%

ROIC (5Y)

18.81%

SBC / revenue

4.47%

Tax / revenue

3.66%

Metric

Value

EPS growth

33.19%

EPS growth (Q)

143.59%

EPS growth (QoQ)

25.83%

EPS growth 10Y

11.37%

EPS growth 3Y

13.44%

EPS growth 5Y

-5.84%

EPS growth years

FCF growth

14.26%

FCF growth (Q)

47.59%

FCF growth (QoQ)

58.74%

FCF growth 3Y

-1.91%

FCF growth 5Y

-7.11%

Gross profit growth

8.37%

Gross profit growth (Q)

4.55%

Gross profit growth 3Y

3.96%

Gross profit growth 5Y

1.26%

Net income growth

29.99%

Net income growth (Q)

137.95%

Net income growth (QoQ)

24.7%

Net income growth 3Y

10.68%

Net income growth 5Y

-7.85%

Net income growth years

OCF growth

14.29%

OCF growth (Q)

-3.08%

OCF growth (QoQ)

-5.1%

OCF growth 10Y

11.79%

OCF growth 3Y

-5.32%

OCF growth 5Y

-10.16%

Operating income growth

30.63%

Operating income growth (Q)

23.7%

Operating income growth 3Y

11.45%

Operating income growth 5Y

-3.16%

Revenue growth

4.42%

Revenue growth (Q)

1.92%

Revenue growth (QoQ)

-3.92%

Revenue growth 10Y

15.12%

Revenue growth 3Y

2.99%

Revenue growth 5Y

2.06%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

BRL -530.7M

Depreciation and amortization

BRL 777.3M

EBIT

BRL 4.3B

EBITDA

BRL 5B

EPS

BRL 9.18

Financing cash flow

BRL -1.6B

Free cash flow

BRL 3.4B

Free cash flow minus SBC

BRL 2.4B

Gross profit

BRL 15.5B

Income taxes

BRL 789.3M

Investing cash flow

BRL -1.5B

Net cash flow

BRL 727.7M

Net income

BRL 2.5B

Operating cash flow minus SBC

BRL 2.9B

Operating income

BRL 4.3B

Revenue

BRL 21.5B

Stock-based compensation

BRL 962.8M

Metric

Value

Book value per share

BRL 314.15

Debt / EBITDA

0.11

Debt / equity

0.03

Debt / FCF

0.17

Goodwill

BRL 2.6B

Long-term assets

BRL 19.2B

Long-term liabilities

BRL 1.2B

Net cash (debt)

BRL 5.3B

Net cash / market cap

9.12%

Net cash growth

16.9%

Net debt / EBITDA

-1.06

Net debt / equity

-0.24

Net debt / FCF

-1.59

Piotroski F-Score

Property, plant and equipment

BRL 6.8B

Shareholders' equity

BRL 22.3B

Tangible book value

BRL 19.3B

Tangible book value per share

BRL 271.40

Total assets

BRL 33.8B

Total cash

BRL 5.9B

Total debt

BRL 581.7M

Total liabilities

BRL 11.5B

WACC

13.32%

Metric

Value

Asset turnover

0.65

Current assets

BRL 14.6B

Current liabilities

BRL 10.2B

Current ratio

1.42

Inventory turnover

5.19

Net working capital

BRL -1.7B

Quick ratio

1.21

Working capital

BRL 4.2B

Working capital turnover

31.21

Metric

Value

Buyback yield / dilution

2.39%

Shareholder yield

2.39%

Metric

Value

150-day SMA

BRL 213.73

1D price change

2.68%

1M price change

8.19%

1M total return

8.19%

1W price change

9.72%

1W total return

9.72%

1Y price change

13.41%

1Y return CAGR

13.42%

1Y total return

13.41%

20-day SMA

BRL 202.25

200-day SMA

BRL 245.75

3M price change

-8.83%

3M total return

-8.83%

3Y price change

-13.52%

3Y return CAGR

-4.73%

3Y total return

-13.52%

50-day SMA

BRL 213.91

50-day SMA vs 200-day SMA

50under200

52-week high

BRL 248.50

52-week high date

2026-02-10

52-week low

BRL 175.00

52-week low date

2026-10-05

5Y price change

-75.55%

5Y return CAGR

-24.55%

5Y total return

-75.55%

6M price change

-10.16%

6M total return

-10.16%

All-time high

BRL 987.05

All-time high date

2021-11-08

All-time low

BRL 164.56

All-time low date

2025-09-30

Average true range (ATR)

BRL 6.79

Average volume

22.5

Beta (5Y)

1.67

Change from 52-week high

-16.7%

Change from 52-week low

18.29%

Change from all-time high

-79.03%

Change from all-time low

25.79%

Change from open

Day's gap

2.68%

Dollar volume

BRL 12,834

High price

BRL 207.00

Low price

BRL 207.00

Monthly RSI

42.49

Open price

BRL 207.00

Previous close

BRL 201.60

Price vs 150-day SMA

-3.15%

Price vs 20-day SMA

2.35%

Price vs 200-day SMA

-15.77%

Price vs 50-day SMA

-3.23%

Relative volume

2.76

RSI

52.04

Sharpe ratio

-0.63

Sharpe ratio (3Y)

0.17

Sortino ratio

-0.69

Sortino ratio (3Y)

0.34

Volume

Weekly RSI

45.44

YTD price change

-5.82%

YTD total return

-5.82%

Metric

Value

Float

66.8M

Shares change (QoQ)

-0.71%

Shares change (YoY)

-2.39%

Shares held by insiders

3.42%

Shares held by institutions

102.95%

BVMF/A1LG34 (BVMF/A1LG34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A1LG34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A1LG34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A1LG34

Frequently asked questions

BVMF/A1LG34 (BVMF/A1LG34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A1LG34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A1LG34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A1LG34

Frequently asked questions